Metformin 500mg

DRUG4 trials

Sponsors

Boehringer Ingelheim, GlaxoSmithKline, Mst.Sumyara Khatun, Jinnah Medical & Dental College

Conditions

Diabetes Mellitus, Type 2Diabetic FootPCOS(Insulin Resistant)Parkinsons Disease (PD)

Phase 2

BE Study of Metformin GSK 500mg

CompletedNCT01710527

GlaxoSmithKlineDiabetic Foot

Start: 2012-05-09End: 2012-05-18Updated: 2017-06-02

Phase 3

Study to Compare the Efficacy and Safety of Administration of the Fix Dose Combination of Linagliptin Plus Metformin in Drug naïve Type 2 Patients

CompletedNCT01708902

Boehringer IngelheimDiabetes Mellitus, Type 2

Start: 2012-10-31End: 2014-04-30Updated: 2015-04-24

Phase 4

Metformin in Parkinson's Disease: Safety and Efficacy

Not yet recruitingNCT07806019

Jinnah Medical & Dental CollegeParkinsons Disease (PD)

Start: 2026-08-28End: 2027-02-01Target: 70Updated: 2026-09-09

Unknown Phase

Melatonin & Metformin on Clinical & Biochemical Parameters in Insulin Resistant PCOS Compared to Metformin

RecruitingNCT07307677

Mst.Sumyara KhatunPCOS(Insulin Resistant)

Start: 2025-03-11End: 2026-08-10Target: 60Updated: 2026-01-07

Related Papers

Early Combination Therapy with Linagliptin and Metformin in People with Type 2 Diabetes Improves Glycemic Control to HbA1c ≤ 6.5% without Increasing Hypoglycemia: Pooled Analysis of Two Randomized Clinical Trials

Diabetes Therapy2020-04-2310 citations